Nasal and paranasal sinus mucosal melanoma: Long-term survival outcomes and prognostic factors.

Autor: Abt NB; Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Miller LE; Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA. Electronic address: lauren_miller@meei.harvard.edu., Mokhtari TE; Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Lin DT; Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Richmon JD; Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Deschler DG; Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Varvares MA; Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Puram SV; Department of Otolaryngology, Washington University School of Medicine, St. Louis, MO, USA.
Jazyk: angličtina
Zdroj: American journal of otolaryngology [Am J Otolaryngol] 2021 Nov-Dec; Vol. 42 (6), pp. 103070. Date of Electronic Publication: 2021 Apr 19.
DOI: 10.1016/j.amjoto.2021.103070
Abstrakt: Objective: To determine prognostic factors and survival patterns for different treatment modalities for nasal cavity (NC) and paranasal sinus (PS) mucosal melanoma (MM).
Methods: Patients from 1973 to 2013 were analyzed using the Surveillance, Epidemiology, and End Results (SEER) database. Kaplan-Meier method and multivariable cox proportional hazard modeling were used for survival analyses.
Results: Of 928 cases of mucosal melanoma (NC = 632, PS = 302), increasing age (Hazard Ratio [HR]:1.05/year, p < 0.001), T4 tumors (HR: 1.81, p = 0.02), N1 status (HR: 6.61, p < 0.001), and PS disease (HR: 1.50, p < 0.001) were associated with worse survival. Median survival length was lower for PS versus NC (16 versus 26 months, p < 0.001). Surgery and surgery + radiation therapy (RT) improved survival over non-treatment or RT alone (p < 0.001). Adding RT to surgery did not yield a survival difference compared with surgery alone (p = 0.43). Five-year survival rates for surgery and surgery + RT were similar, at 27.7% and 25.1% (p = 0.43).
Conclusion: Surgery increased survival significantly over RT alone. RT following surgical resection did not improve survival.
(Copyright © 2021 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: